Therapeutic Asset Ratings
1,531 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
SDM-8
REM Sleep Behavior Disorder
Universitaire Ziekenhuizen KU Leuven
N/A
D
(30)
Semaglutide
Bipolar Disorder
Ludwig-Maximilians - University of Munich
N/A
D
(30)
Semaglutide
Fatty Liver Disease
Insel Gruppe AG, University Hospital Bern
N/A
D
(30)
Semaglutide
Glucose Metabolism Disease
RenJi Hospital
N/A
D
(30)
Semaglutide
Inherited Lipid Metabolism Disorder
RenJi Hospital
N/A
D
(30)
Semaglutide
Adrenal Gland Hyperfunction
University of Texas Southwestern Medical Center
N/A
D
(30)
Semaglutide
Psychiatric Disorder
Ludwig-Maximilians - University of Munich
N/A
D
(30)
Semaglutide
Skeletal Muscle Disorder
Washington University School of Medicine
N/A
D
(30)
Semaglutide
Cushing Syndrome
University of Texas Southwestern Medical Center
N/A
D
(30)
Senl_B19 Autologous Car-T Treatment
B-Cell Acute Lymphoblastic Leukemia
Peking University People's Hospital
N/A
D
(30)
Senl_B19 Autologous Car-T Treatment
Acute Lymphoblastic Leukemia
Peking University People's Hospital
N/A
D
(30)
Senl_B19 Autologous Car-T Treatment
Adult Acute Lymphoblastic Leukemia
Peking University People's Hospital
N/A
D
(30)
Senl_B19 Autologous Car-T Treatment
Childhood Acute Lymphoblastic Leukemia
Peking University People's Hospital
N/A
D
(30)
Senl-T7
Precursor T-Cell Acute Lymphoblastic Leukemia
Hebei Senlang Biotechnology Inc., Ltd.
N/A
D
(30)
Serplulimab
Metastasis From Malignant Tumor Of Colon
Henan Cancer Hospital
N/A
D
(30)
Sevoflurane
Malignant Colon Neoplasm
Seoul National University Hospital
N/A
D
(30)
Sevoflurane
Cognitive Disorder
Gaziantep City Hospital
N/A
D
(30)
Sildenafil
Migraine Without Aura
Danish Headache Center
N/A
D
(30)
Simethicone
Irritable Bowel Syndrome
University of Pecs
N/A
D
(30)
Simethicone
Lactose Intolerance
University of Pecs
N/A
D
(30)
SIMVASTATIN
Acute Kidney Injury
Post Graduate Institute of Medical Education and Research, Chandigarh
N/A
D
(30)
SIMVASTATIN
Cardiomyopathy
Post Graduate Institute of Medical Education and Research, Chandigarh
N/A
D
(30)
SIMVASTATIN
Diastolic Heart Failure
Post Graduate Institute of Medical Education and Research, Chandigarh
N/A
D
(30)
Sirolimus
Hormone-Resistant Breast Carcinoma
Fudan University
N/A
D
(30)
Sitagliptin
Hyperlipidemia
Mais Qais Hbeeb
N/A
D
(30)
Showing 1051 to 1075 of 1,531 assets
Previous
Page 43 of 62
Next